等待开盘 02-05 09:30:00 美东时间
-0.260
-0.46%
Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm these fees act as an industry "vig" driving up prices.
01-16 15:30
Healthcare ETFs stay resilient as Big Pharma agrees to Medicaid drug price cuts. Here's what is cushioning ETFs despite pricing pressure.
2025-12-20 04:17
If nominal GDP and earnings growth accelerate due to higher inflation, stocks’ valuation may see a support ahead, according to Michael J. Wilson, chief U.S. equity strategist and chief investment offi...
2025-10-07 00:51
Drug pricing policy clarity from the Trump administration could signal a turning point for pharmaceutical stocks (PPH), (PJP), (NYSEARCA:XPH), which have been among the worst performers this year with...
2025-10-02 02:51
The U.S. pharmaceutical industry is at the center of a policy maelstrom.
2025-09-30 00:06
President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.
2025-09-29 15:20
European and Asian pharmaceutical stocks fell Friday after President Donald Trump unveiled sweeping new tariffs, including a 100% levy on branded and patented drugs starting October 1, with exemptions...
2025-09-26 16:59
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
2025-09-08 13:49
PNC asset management chief investment strategist Yung-Yu Ma believes market pullbacks present buying opportunities despite growing concerns about weakening labor trends, as the market initially reacte...
2025-09-06 00:02
Citigroup’s director of U.S. equity strategy Drew Pettit described recent market declines as a “healthy reset” rather than a reason for alarm. In an interview with CNBC, Pettit emphasized that despite...
2025-09-03 03:38